Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators

NACompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
AsthmaMajor Depressive Disorder
Interventions
OTHER

Non-Interventional

This is a 52 week non-placebo controlled and non-randomized clinical research study to see whether treating Major Depressive Disorder (MDD) in caregivers of children with asthma will improve asthma outcomes in children. Caregivers may choose to receive an antidepressant medication that is considered standard medical care for MDD, or may opt out of antidepressant treatment. No treatment is withheld from participants and no placebos are used, thus there is no active intervention in this study.

Trial Locations (1)

75235

University of Texas Southwestern Medical Center Psychoneuroendocrine Research Program, Dallas

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University at Buffalo

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT02809677 - Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators | Biotech Hunter | Biotech Hunter